ReviewCureus2022

The Impact of Recombinant Versus Plasma-Derived Factor VIII Concentrates on Inhibitor Development in Previously Untreated Patients With Hemophilia A: A 2021 Update of a Systematic Review and Meta-Analysis.

Kelvin Kohar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.